MinervaX ApS, a privately held Danish biotechnology company developing a novel, prophylactic vaccine against Group B Streptococcus (GBS), today announced the appointment of Veronica Gambillara Fonck ...
1h
Hørsholm, Denmark, 14 November 2024 - ExpreS2ion Biotech Holding AB ("ExpreS2ion") today announces its third quarter and year-to-date financial results for 2024. The report is available as an attachme ...
Combination vaccines can ease the logistics of vaccine management ... This has been apparent in recent outbreaks in the UK, ...
Join the GenScript Biotech Global Forum in London to Navigate the Future of Cell and Gene Therapies.
The global cell and gene therapy (CGT) industry is poised for remarkable growth, driven by significant advances in life ...
As anticipated, Evaxion has received a delisting determinationThe determination has been appealed by Evaxion requesting a hearing on the matter and seeking another 180-day extension to comply with Nas ...
U.S-based Catalent, one of the world's largest contract manufacturers, made a huge windfall during the COVID-19 pandemic as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback